A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001). (NCT06655324)
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants.
🩺 Plain-English Summary (8th-Grade Level)
Epstein Barr virus (EBV) is a virus which can cause infectious mononucleosis and is associated with certain kinds of cancer and multiple sclerosis. Researchers are looking for new ways to prevent disease related to EBV and have developed a new study vaccine (V350A and V350B). The main goal of this study is to learn about the safety and tolerability of V350A and V350B in healthy adults.
Who can join: Review the eligibility criteria below.
Location: California Clinical Trials Medical Group managed by PAREXEL ( Site 0011) — Glendale, California
Age range: 12 Years to 30 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (9 Sites)
- California Clinical Trials Medical Group managed by PAREXEL ( Site 0011) — Glendale, California
- QPS-MRA, LLC ( Site 0012) — Miami, Florida
- Alliance for Multispecialty Research, LLC ( Site 0008) — Kansas City, Missouri
- Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0016) — Springfield, Missouri
- Velocity Clinical Research Lincoln ( Site 0004) — Lincoln, Nebraska
- Velocity Clinical Research, Omaha ( Site 0005) — Omaha, Nebraska
- Remington-Davis, Inc. ( Site 0017) — Columbus, Ohio
- Lynn Health Science Institute ( Site 0010) — Oklahoma City, Oklahoma
- Alliance for Multispecialty Research, LLC ( Site 0009) — Knoxville, Tennessee
📞 Contact the Study Coordinator
Phone: (888) 577-8839
Email: Trialsites@msd.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Healthy
- Xanthohumol Metabolism and Signature — Portland, Oregon
- Examining the Effects of Regular Brief Internet-based Meditation Practice on Mental Health and Well Being — Stanford, California
- A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions — Detroit, Michigan
- A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004) — Hollywood, Florida
- Pediatric Parenting Support in Flint — Flint, Michigan
- Biomarker-estimated Flavanol Intake in Davis (FID) — Davis, California
Explore by condition: All Healthy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.